当前位置:首页 - 行情中心 - 兰卫医学(301060) - 财务分析 - 现金流量表

兰卫医学

(301060)

  

流通市值:35.37亿  总市值:39.33亿
流通股本:3.60亿   总股本:4.01亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金781,733,754.17401,580,869.232,071,076,712.391,398,283,862.09
  收到的税费返还--5,871,422.87-
  收到其他与经营活动有关的现金12,249,793.745,032,851.8741,976,547.4221,188,266.56
  经营活动现金流入小计793,983,547.91406,613,721.12,118,924,682.681,419,472,128.65
  购买商品、接受劳务支付的现金527,988,600.72289,296,873.441,449,557,377.11,094,679,551.73
  支付给职工以及为职工支付的现金135,944,398.6270,124,452.22273,902,848.55198,637,481.53
  支付的各项税费28,103,565.359,937,391.7254,301,614.4937,785,487.09
  支付其他与经营活动有关的现金64,712,886.1835,596,870.71124,850,026.36116,644,123.64
  经营活动现金流出小计756,749,450.87404,955,588.091,902,611,866.51,447,746,643.99
  经营活动产生的现金流量净额37,234,097.041,658,133.01216,312,816.18-28,274,515.34
二、投资活动产生的现金流量:
  收回投资收到的现金748,100,000254,800,000230,000,000170,000,000
  取得投资收益收到的现金1,596,141.54379,614.39630,098.63576,164.38
  处置固定资产、无形资产和其他长期资产收回的现金净额2,036,417.98725,6915,601,966.353,075,909
  处置子公司及其他营业单位收到的现金净额3,331,500131,5003,802,130.73,602,130.7
  投资活动现金流入小计755,064,059.52256,036,805.39240,034,195.68177,254,204.08
  购建固定资产、无形资产和其他长期资产支付的现金22,704,958.511,872,288.1576,615,801.8451,759,068.61
  投资支付的现金748,100,000309,700,000232,000,000174,000,000
  投资活动现金流出小计770,804,958.5321,572,288.15308,615,801.84225,759,068.61
  投资活动产生的现金流量净额-15,740,898.98-65,535,482.76-68,581,606.16-48,504,864.53
三、筹资活动产生的现金流量:
  吸收投资收到的现金--3,560,0003,480,000
  其中:子公司吸收少数股东投资收到的现金--3,560,0003,480,000
  取得借款收到的现金50,000,000-122,930,000122,930,000
  筹资活动现金流入平衡项目0-00
  筹资活动现金流入小计50,000,000-126,490,000126,410,000
  偿还债务支付的现金92,500,0007,500,000221,716,000186,400,000
  分配股利、利润或偿付利息支付的现金90,028,798.248,787,262.5157,906,726.3619,630,274.82
  其中:子公司支付给少数股东的股利、利润--50,550,00012,495,000
  支付其他与筹资活动有关的现金7,419,098.523,421,266.7827,121,761.6719,882,064.06
  筹资活动现金流出小计189,947,896.7619,708,529.29306,744,488.03225,912,338.88
  筹资活动产生的现金流量净额-139,947,896.76-19,708,529.29-180,254,488.03-99,502,338.88
四、汇率变动对现金及现金等价物的影响-22,973.6-22,811.22--365,611.18
五、现金及现金等价物净增加额-118,477,672.3-83,608,690.26-32,523,278.01-176,647,329.93
  加:期初现金及现金等价物余额825,747,324.57825,747,324.57858,270,602.58858,270,602.58
  期末现金及现金等价物余额707,269,652.27742,138,634.31825,747,324.57681,623,272.65
补充资料:
  净利润-3,806,701.02--98,590,178.09-
  资产减值准备18,669,341.3-103,406,254.98-
  固定资产和投资性房地产折旧29,287,708.23-58,732,375.93-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧29,287,708.23-58,732,375.93-
  无形资产摊销2,508,922.77-5,595,013.27-
  长期待摊费用摊销7,129,829.73-25,642,978.2-
  处置固定资产、无形资产和其他长期资产的损失31,336.55--5,877,665.59-
  固定资产报废损失547,565.46-2,128,981.97-
  公允价值变动损失-51,715.73---
  财务费用3,608,251.42-10,808,964.34-
  投资损失1,822,039.79--892,029.82-
  递延所得税-170,346.64--24,870,207.04-
  其中:递延所得税资产减少753,158.36--25,318,056.85-
    递延所得税负债增加-923,505-447,849.81-
  存货的减少-28,907,838.33-9,431,562.18-
  经营性应收项目的减少-28,278,756.52-218,805,727.34-
  经营性应付项目的增加28,045,934.91--121,582,827.52-
  其他799,587.53-19,932,470.39-
  现金的期末余额707,269,652.27-825,747,324.57-
  减:现金的期初余额825,747,324.57-858,270,602.58-
  现金及现金等价物的净增加额-118,477,672.3--32,523,278.01-
公告日期2025-08-262025-04-282025-04-282024-10-30
审计意见(境内)标准无保留意见
TOP↑